The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
Open accessAbstract
Respiratory syncytial virus (RSV) is a cause of severe respiratory illness in older adults. In May 2023, the Food and Drug Administration approved the first vaccines for prevention of RSV-associated lower respiratory tract disease in adults aged ≥60 years. Since May 2022, the Advisory Committee on Immunization Practices (ACIP) Respiratory Syncytial Virus Vaccines Adult Work Group met at least monthly to review available evidence regarding the safety, immunogenicity, and efficacy of these vaccines among adults aged ≥60 years. On June 21, 2023, ACIP voted to recommend that adults aged ≥60 years may receive a single dose of an RSV vaccine, using shared clinical decision-making. This report summarizes the body of evidence considered for this recommendation and provides clinical guidance for the use of RSV vaccines in adults aged ≥60 years. RSV vaccines have demonstrated moderate to high efficacy in preventing RSV-associated lower respiratory tract disease and have the potential to prevent substantial morbidity and mortality among older adults; postmarketing surveillance will direct future guidance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
Papi, A., Ison, M. G., Langley, J. M., Lee, D.-G., Leroux-Roels, I., Martinon-Torres, F., Schwarz, T. F., van Zyl-Smit, R. N., Campora, L., Dezutter, N., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2209604 · Cited by 774
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
Walsh, E. E., Pérez Marc, G., Zareba, A. M., Falsey, A. R., Jiang, Q., Patton, M., Polack, F. P., Llapur, C., Doreski, P. A., Ilangovan, K., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2213836 · Cited by 668
Respiratory syncytial virus infection in adults
Nam, H. H., & Ison, M. G. (2019) · BMJ · doi:10.1136/bmj.l5021 · Cited by 332
Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017–2020
Branche, A. R., Saiman, L. M., Walsh, E. E., Falsey, A. R., Sieling, W. D., Greendyke, W. G., Peterson, D. R., Vargas, C. Y., Phillips, M., & Finelli, L. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab595 · Cited by 275
Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018
Hansen, C. L., Chaves, S. S., Demont, C., & Viboud, C. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0527 · Cited by 251
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis
McLaughlin, J. M., Khan, F., Begier, E., Swerdlow, D. L., Jodar, L., & Falsey, A. R. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac300 · Cited by 224
Onwuchekwa, C., Moreo, L. M., Menon, S., Machado, B., Curcio, D., Kalina, W., Atwell, J. E., Gessner, B. D., Siapka, M., Agarwal, N., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad012 · Cited by 205
Matias, G., Taylor, R., Haguinet, F., Schuck‐Paim, C., Lustig, R., & Shinde, V. (2014) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12258 · Cited by 177
Waghmare, A., Campbell, A. P., Xie, H., Seo, S., Kuypers, J. M., Leisenring, W. M., Jerome, K. R., Englund, J. A., & Boeckh, M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit639 · Cited by 133
Cited by
Fleming-Dutra, K. E., Jones, J. M., Roper, L. E., Prill, M. M., Ortega-Sanchez, I. R., Moulia, D. L., Wallace, M., Godfrey, M., Broder, K. R., Tepper, N. K., et al. (2023) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7241e1 · Cited by 309
Self-citationThe Impact of Immune System Aging on Infectious Diseases
Quiros-Roldan, E., Sottini, A., Natali, P. G., & Imberti, L. (2024) · Microorganisms · doi:10.3390/microorganisms12040775 · Cited by 133
“…Committee on Immunization Practices of Centers for Disease Control and Prevention recommends that adults over 65 years obtain immunization against herpes zoster virus, Streptococcus pneumoniae , influenza viruses [104], and more recently, RSV in those over 60 years [239], and SARS-CoV-2 [104].”
Metadata
- Authors
- Melgar, M., Britton, A., Roper, L. E., Talbot, H. K., Long, S. S., Kotton, C. N., & Havers, F. P.
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2023-07-21
- Volume
- 72
- Issue
- 29
- Pages
- 793-801
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W4384926015
- Cited by
- 328
- References
- 14
- FWCI
- 54.69
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. https://app.cochat.ai/papers/10.15585/mmwr.mm7229a4
- The paper
- Melgar, M., Britton, A., Roper, L. E., Talbot, H. K., Long, S. S., Kotton, C. N., & Havers, F. P. (2023). Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7229a4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.